Specifications

• Pk:
  100 µG
• Conjugation:
  Unconjugated
• Protein/peptide type:
  Recombinant
• Source:
  HEK293 cells
• Species:
  Human
• Seq:
  01
• Storage conditions:
  –20 °C
• Endotoxin content:
  Less than 0,01 EU per μg by the LAL method.
• Biological activity:
  Lyophilised from 0,22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 150 mM NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation. Measured by its binding ability in a functional ELISA. Immobilised Human BAFF, His Tag (Cat. No. BAF-H5248) at 5 μg/ml (100 μl/well) can bind Human BCMA, Llama IgG2b Fc Tag (Cat. No. BCA-H5259) with a linear range of 0,02 - 0,4 ng/ml (QC tested). Measured by its binding ability in a functional ELISA. Immobilised Human BCMA, Llama IgG2b Fc Tag (Cat. No. BCA-H5259) at 2 μg/ml (100 μl/well) can bind Anti-Human BCMA Mab with a linear range of 0,4 - 3 ng/ml (Routinely tested).
• Gene ID:
  Q02223-1
• Carrier-free:
  Y
• Protease-free:
  Y
• Animal-free:
  Y
• Protein synonyms:
  CD269|TNFRSF17|BCM
• Protein/peptide name:
  BCMA
• Purity:
  >90%
• Molecular weight:
  33,7 kDa
• Endotoxin level:
  Low
• Formulation:
  Lyophilised from 0,22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 150 mM NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation.
• Nuclease-free:
  Y
• Shipping temperature:
  Powder, RT